-
EP3897721
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3897721
| EP3897721 - METHODS OF USING BUTYROPHILIN ANTIBODIES FOR TREATING HIV INFECTION [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.02.2024 Database last updated on 03.09.2024 | |
| Former | Request for examination was made Status updated on 24.09.2021 | ||
| Former | The international publication has been made Status updated on 02.07.2020 | Most recent event Tooltip | 24.08.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states Merck Sharp & Dohme LLC 126 East Lincoln Avenue Rahway, New Jersey 07065 / US | [2022/42] |
| Former [2021/43] | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Road Rahway, New Jersey 07065-0907 / US | Inventor(s) | 01 /
HOWELL, Bonnie Jean 770 Sumneytown Pike West Point, Pennsylvania 19486 / US | 02 /
MENG, Hsien-Wei Yvonne 33 Avenue Louis Pasteur Boston, Massachusetts 02115-5727 / US | 03 /
MONSLOW, Morgan Ann 770 Sumneytown Pike West Point, Pennsylvania 19486 / US | 04 /
SHAHEEN, Hussam Hisham 33 Avenue Louis Pasteur Boston, Massachusetts 02115-5727 / US | 05 /
VEMULA, Sai Vikram 2000 Galloping Hill Road Kenilworth, New Jersey 07033 / US | [2021/43] | Representative(s) | Merck Sharp & Dohme LLC 120 Moorgate London EC2M 6UR / GB | [N/P] |
| Former [2021/43] | Böhles, Elena Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | Application number, filing date | 19901033.1 | 17.12.2019 | [2021/43] | WO2019US66683 | Priority number, date | US201862781204P | 18.12.2018 Original published format: US 201862781204 P | [2021/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020131764 | Date: | 25.06.2020 | Language: | EN | [2020/26] | Type: | A1 Application with search report | No.: | EP3897721 | Date: | 27.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.06.2020 takes the place of the publication of the European patent application. | [2021/43] | Search report(s) | International search report - published on: | US | 25.06.2020 | (Supplementary) European search report - dispatched on: | EP | 11.08.2022 | Classification | IPC: | A61K39/395, A61P31/18, C07K16/28 | [2021/43] | CPC: |
C07K16/2803 (EP,US);
A61P31/18 (EP);
C07K2317/30 (US);
C07K2317/33 (EP);
C07K2317/70 (EP);
C07K2317/76 (EP,US);
C07K2317/92 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/43] | Title | German: | VERFAHREN ZUR VERWENDUNG VON BUTYROPHILINANTIKÖRPERN ZUR BEHANDLUNG VON HIV-INFEKTIONEN | [2021/43] | English: | METHODS OF USING BUTYROPHILIN ANTIBODIES FOR TREATING HIV INFECTION | [2021/43] | French: | PROCÉDÉS D'UTILISATION D'ANTICORPS DE BUTYROPHILINE POUR LE TRAITEMENT D'UNE INFECTION PAR LE VIH | [2021/43] | Entry into regional phase | 19.07.2021 | National basic fee paid | 19.07.2021 | Search fee paid | 19.07.2021 | Designation fee(s) paid | 19.07.2021 | Examination fee paid | Examination procedure | 18.06.2021 | Observations by third parties | 19.07.2021 | Examination requested [2021/43] | 15.03.2023 | Amendment by applicant (claims and/or description) | 07.02.2024 | Despatch of a communication from the examining division (Time limit: M06) | 23.08.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Request for further processing for: | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 15.03.2023 | Request for further processing filed | 15.03.2023 | Full payment received (date of receipt of payment) Request granted | 27.03.2023 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 15.03.2023 | Request for further processing filed | 15.03.2023 | Full payment received (date of receipt of payment) Request granted | 27.03.2023 | Decision despatched | Fees paid | Renewal fee | 16.12.2021 | Renewal fee patent year 03 | 09.12.2022 | Renewal fee patent year 04 | 12.12.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2015353643 (OLIVE DANIEL [FR], et al) [X] 1-13 * paragraph [0158]; claim - * * paragraph [0216] * * paragraph [0328] *; | [Y] - Felipe Rubén ET AL, "Section of Infection and Immunity Submitted by", (20160101), URL: https://opus.bibliothek.uni-wuerzburg.de/opus4-wuerzburg/frontdoor/deliver/index/docId/14208/file/Riano_Arias_Ruben_Felipe_T_cells.pdf, (20220719), XP055944035 [Y] 1-13 * Third Party Citation; page 14 * * page 20; figure 1 * * page 46; figure 4 * * page 49 - page 51 * * page 91 * * page 98 - page 99 * | [Y] - HEATHER A. ARNETT ET AL, "Immune modulation by butyrophilins", NATURE REVIEWS IMMUNOLOGY, London, (20140725), vol. 14, no. 8, doi:10.1038/nri3715, ISSN 1474-1733, pages 559 - 569, XP055352130 [Y] 1-13 * page 561 - page 562 * * page 564 - page 566 * * figures F3a,b,e * DOI: http://dx.doi.org/10.1038/nri3715 | [Y] - APARNA PALAKODETI ET AL, "The Molecular Basis for Modulation of Human V?9V?2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20120921), vol. 287, no. 39, doi:10.1074/jbc.M112.384354, ISSN 0021-9258, pages 32780 - 32790, XP055562786 [Y] 1-13 * page 32870 * * page 32871 * * page 32783; figure 2 * * page 32789 * DOI: http://dx.doi.org/10.1074/jbc.M112.384354 | [Y] - C. DAVID PAUZA ET AL, "γΠ́ T Cells in HIV Disease: Past, Present, and Future", FRONTIERS IN IMMUNOLOGY, (20150130), vol. 5, doi:10.3389/fimmu.2014.00687, XP055718000 [Y] 1-13 * page 1 - page 2 * * page 6 * DOI: http://dx.doi.org/10.3389/fimmu.2014.00687 | International search | [X]WO2012080769 (INST NAT SANTE RECH MED [FR], et al) [X] 1-2, 3/1-2, 4-9 * ; page 22. lines 1-3; page 23, lines 18-22; page 37, line 26-page 38, line 5: page 44, lines 9-29 *; | [Y] - Yueshui Zhao, Ling Lin, Zhangang Xiao, Mingxing Li, Xu Wu, Wanping Li, Xiaobing Li, Qijie Zhao, Yuanlin Wu, Hanyu Zhang, Jianhua Yin, Lingling Zhang, Chi Hin Cho, Jing Shen, "Protective Role of [gamma-delta) T Cells in Different Pathogen Infections and Its Potential Clinical Application", Journal of Immunology Research, (20180710), vol. 2018, pages 1 - 15, XP055721894 [Y] 7 * , Article ID 5081634, pages 1-15; page 5, 1st column, 3rd paragraph - page 5. 2nd column, 3rd paragraph; page 8, 1st column, 2nd paragraph; DOI: 10.1155/2018/5081634 * DOI: http://dx.doi.org/10.1155/2018/5081634 | [A] - Harly C; Guillaume Y; Nedellec S; C-M Peigne; Monkkonen H; Monkkonen J; Li J; Kuball J; Adams E J; Netzer S; Dechanet-Merville J; Leger A; Herrmann T; Breathnach R; Olive D; Bonneville M; Scotet E, "Key implication of CD 277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gamma-delta T- cell subset", Blood, (20120913), vol. 120, no. 11, pages 2269 - 2279, XP055081172 [A] 1-2, 3/1-2, 4-9 * ; entire document; DOI: 10.1182/blood-2012-05-430470 * DOI: http://dx.doi.org/10.1182/blood-2012-05-430470 |